Skip to main content
Dan Longo, MD, Oncology, Brookline, MA

DanL.LongoMD

Oncology • Brookline, MA

Professor of Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Longo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Longo's full profile

Already have an account?

  • Office

    111 Cypress St
    Brookline, MA 02445
    Phone+1 857-307-0896
    Fax+1 410-350-3979

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1975

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1977 - 2026
  • MA State Medical License
    MA State Medical License 1976 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • SARS-CoV-2 Vaccination — an Ounce (Actually, Much Less) of Prevention  
    Eric J Rubin, Dan L Longo, The New England Journal of Medicine
  • Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade  
    R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
  • Plateletpheresis-Associated Lymphopenia in Frequent Platelet Donors  
    Michael B Brenner, John M Gansner, A Helena Jonsson, Dan L Longo, Jason M Schenkel, Deepak A Rao, Richard M Kaufman, Nancy Berliner, Duane R Wesemann, Blood

Abstracts/Posters

  • Macrophage Checkpoint Blockade in Cancer — Back to the Future
    Dan Longo, MD, The New England Journal of Medicine, Orlando, FL, 12/8/2019

Press Mentions

  • Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma
    Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin LymphomaNovember 14th, 2024
  • Immunotherapy Improves Survival in People with Advanced Hodgkin Lymphoma, Study Shows
    Immunotherapy Improves Survival in People with Advanced Hodgkin Lymphoma, Study ShowsOctober 16th, 2024
  • Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin’s Lymphoma
    Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin’s LymphomaOctober 16th, 2024
  • Join now to see all

Grant Support

  • The Reveal StudyNational Institute On Aging2009
  • Structure-Function Relationship Of NFKB P65National Institute On Aging2009
  • Shaping The Preimmune B Cell RepertoireNational Institute On Aging2009
  • Role Of Hyperplasia Suppressor Gene (HSG) In Cell Growth.National Institute On Aging2009
  • Rapamycin-Sensitive Pathway Of T Cell ActivationNational Institute On Aging2009
  • Long-Term Consequences Of Lymphoma And Its TreatmentNational Institute On Aging2009
  • Cytapheresis Of Volunteer Donors (Mri 2003-054)National Institute On Aging2009
  • Characterization Of Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2009
  • Acute Leukemia In The Elderly: Development Of Novel, Targeted TherapeuticsNational Institute On Aging2009
  • Acute Leukemia In The Elderly: Development Of Novel, Targeted TherapeuticsNational Institute On Aging2008
  • Characterization Of Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2007–2008
  • Structure-Function Relationship Of NFKB P65National Institute On Aging2005–2008
  • Rapamycin-Sensitive Pathway Of T Cell ActivationNational Institute On Aging2005–2008
  • Shaping The Preimmune B Cell RepertoireNational Institute On Aging2002–2008
  • Tumor-Induced ImmunosuppressionNational Institute On Aging2002–2007
  • Cell Biology Of LymphomaNational Institute On Aging2000–2007
  • Characterization Of Tgf-B Signaling In A B-Cell LymphomaNational Institute On Aging2006
  • Characterization Of Tgf-B Signaling In B-Cell LymphomaNational Institute On Aging2005
  • Role Of SMAD3 In Tgf-B Signaling In A B-Cell Lymphoma CENational Institute On Aging2004
  • Role Of PTEN In T Cell ActivationNational Institute On Aging2002–2004
  • Cyclosporin A-Resistant Co-Stimulation VIA CD28National Institute On Aging2002–2004
  • Regulation Of Mutant P53National Institute On Aging2000–2004
  • SMAD3 In Tgf-B Signaling In B Cell Lymphoma Cell LINENational Institute On Aging2003
  • SMAD3 In Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2002
  • Regulation Of Interferon-Gamma Gene In Freshly DifferentNational Institute On Aging2002
  • Regulation Of Interferon-Gamma Gene In TH1 And TH2 CellsNational Institute On Aging2001
  • Cyclosporin A Resistant Costimulation VIA CD28National Institute On Aging2001
  • Tumor Induced ImmunosuppressionNational Institute On Aging2000–2001
  • Role Of Cadherins In Tumor ProgressionNational Institute On Aging2000–2001
  • Role Of SAP In Lymphocyte Sub PopulationsNational Institute On Aging2000
  • Cyclosporin A Resistant CO Stimulation VIA CD28National Institute On Aging2000
  • Host Tumor InteractionsNational Institute On Aging1999

Professional Memberships

Dr. Dan Longo, Dr. Dan Longo, MD, Dr. D Longo, Dr. Dan L. Longo